» Articles » PMID: 15894612

The Activating NKG2D Receptor Assembles in the Membrane with Two Signaling Dimers into a Hexameric Structure

Overview
Specialty Science
Date 2005 May 17
PMID 15894612
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

The activating NKG2D receptor plays a critical role in innate and adaptive immune responses by natural killer cells and subpopulations of T cells. The human receptor assembles with the DAP10 signaling dimer, and it is thought that one NKG2D homodimer pairs with a single DAP10 dimer by formation of two salt bridges between charged transmembrane (TM) residues. However, direct stoichiometry measurements demonstrated that one NKG2D homodimer assembles with four DAP10 chains. Selective mutation of one of the basic TM residues of NKG2D resulted in loss of two DAP10 chains, indicating that each TM arginine serves as an interaction site for a DAP10 dimer. Assembly of the hexameric structure was cooperative because this mutation also significantly reduced NKG2D dimerization. A monomeric NKG2D TM peptide was sufficient for assembly with a DAP10 dimer, indicating that the interaction between these proteins occurs in the membrane environment. Formation of a three-helix interface among the TM domains involved ionizable residues from all three chains, the TM arginine of NKG2D and both TM aspartic acids of the DAP10 dimer. The organization of the TM domains thus shows similarities to the T cell antigen receptor-CD3 complex, in particular to the six-chain assembly intermediate between T cell antigen receptor and the CD3delta epsilon and CD3gamma epsilon dimers. Binding of a single ligand can thus result in phosphorylation of four DAP10 chains, which may be relevant for the sensitivity of NKG2D receptor signaling, in particular in situations of low ligand density.

Citing Articles

A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells.

Yi E, Lee E, Park H, Lee H, Yun S, Kim H J Exp Clin Cancer Res. 2025; 44(1):86.

PMID: 40045373 PMC: 11884141. DOI: 10.1186/s13046-025-03351-5.


Preformed mincle dimers stabilized by an interchain disulfide bond in the neck region.

Liu Y, Drickamer K, Taylor M Glycobiology. 2024; 34(12).

PMID: 39361919 PMC: 11632378. DOI: 10.1093/glycob/cwae083.


Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys.

Rupert P, Buerger M, Girard E, Frutoso M, Parrilla D, Ng K Heliyon. 2024; 10(7):e28583.

PMID: 38586421 PMC: 10998067. DOI: 10.1016/j.heliyon.2024.e28583.


Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases.

Mittelheisser V, Gensbittel V, Bonati L, Li W, Tang L, Goetz J Nat Nanotechnol. 2024; 19(3):281-297.

PMID: 38286876 DOI: 10.1038/s41565-023-01535-8.


Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances.

Canichella M, Molica M, Mazzone C, de Fabritiis P Cancers (Basel). 2024; 16(1).

PMID: 38201469 PMC: 10777995. DOI: 10.3390/cancers16010042.


References
1.
Cerwenka A, Baron J, Lanier L . Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A. 2001; 98(20):11521-6. PMC: 58762. DOI: 10.1073/pnas.201238598. View

2.
Groh V, Rhinehart R, Randolph-Habecker J, Topp M, Riddell S, Spies T . Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol. 2001; 2(3):255-60. DOI: 10.1038/85321. View

3.
Li P, McDermott G, Strong R . Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. Immunity. 2002; 16(1):77-86. DOI: 10.1016/s1074-7613(02)00258-3. View

4.
Vivier E, Tomasello E, Paul P . Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?. Curr Opin Immunol. 2002; 14(3):306-11. DOI: 10.1016/s0952-7915(02)00337-0. View

5.
Arase H, Mocarski E, Campbell A, Hill A, Lanier L . Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002; 296(5571):1323-6. DOI: 10.1126/science.1070884. View